Drug Industry Antitrust Act, 87-1&2 |
From inside the book
Results 1-5 of 100
Page
... Therapy - The Price We Pay , " Dr. David P. Barr , J.A.M.A. , December 10 , 1955 . 39. " The Testing of New Drugs and Other Therapeutic Agents , " Dr. Isaac Starr , J.A.M.A. , July 8 , 1961 . 815 820 40. " Do Trade Name Drugs Cost Extra ...
... Therapy - The Price We Pay , " Dr. David P. Barr , J.A.M.A. , December 10 , 1955 . 39. " The Testing of New Drugs and Other Therapeutic Agents , " Dr. Isaac Starr , J.A.M.A. , July 8 , 1961 . 815 820 40. " Do Trade Name Drugs Cost Extra ...
Page 28
... therapeutic effect of the modified drug or com- bination of drugs is significantly greater than the therapeutic effect of the drug before modification , or the drugs in combination when taken separately . Unless there is such a greater ...
... therapeutic effect of the modified drug or com- bination of drugs is significantly greater than the therapeutic effect of the drug before modification , or the drugs in combination when taken separately . Unless there is such a greater ...
Page 44
... therapy , and his profes- sional responsiblility to his patient , act as powerful barriers to the sale of useless drugs . Secondary barriers exist in the adverse eco- nomic results which would generally follow for a pharmaceutical ...
... therapy , and his profes- sional responsiblility to his patient , act as powerful barriers to the sale of useless drugs . Secondary barriers exist in the adverse eco- nomic results which would generally follow for a pharmaceutical ...
Page 47
... therapeutic value . F. Each monograph appearing in J.A.M.A. or N.N.D. will be prefaced by a sum- mary of the council opinion ... therapy , the Department of Drugs will be responsible for pro- viding copy , monographs , or council comment ...
... therapeutic value . F. Each monograph appearing in J.A.M.A. or N.N.D. will be prefaced by a sum- mary of the council opinion ... therapy , the Department of Drugs will be responsible for pro- viding copy , monographs , or council comment ...
Page 48
... therapy , etc. , should be included . III . OTHER STAFF ACTIVITIES A. The Department of Drugs will undertake to review , whenever possible , articles on drugs considered for publication in any of the AMA scientific publi- cations , and ...
... therapy , etc. , should be included . III . OTHER STAFF ACTIVITIES A. The Department of Drugs will undertake to review , whenever possible , articles on drugs considered for publication in any of the AMA scientific publi- cations , and ...
Contents
617 | |
638 | |
648 | |
667 | |
688 | |
697 | |
901 | |
929 | |
359 | |
405 | |
457 | |
459 | |
468 | |
470 | |
483 | |
490 | |
525 | |
528 | |
530 | |
538 | |
549 | |
556 | |
558 | |
566 | |
576 | |
600 | |
971 | |
979 | |
992 | |
998 | |
1036 | |
1059 | |
1067 | |
1078 | |
1089 | |
1108 | |
1118 | |
1119 | |
1125 | |
1139 | |
1153 | |
1179 | |
1189 | |
Other editions - View all
Common terms and phrases
agency agents American Medical Association amphetamine antibiotics Betamethasone bill Board of Trustees CELESTONE Chairman chemical CHERKASKY CHUMBRIS claims clinical committee corticosteroids Council Acceptance council on drugs diabetes direct mail doctors dosage doses Drug Administration drug application drug companies drug industry Education efficacy Estes Kefauver ethical drug manufacturer evaluation exhibit experience fact FINLAND firms FLURRY Food and Drug gammanym GOODMAN Health hospital House of Delegates HOWARD HUSSEY increase insulin JAMA laboratory LARRICK LASAGNA medical advertising medical journals medical profession medicine meprobamate nonproprietary names official name patients percent Pfizer phenformin physicians practice prescribe prescription present problem promotion proposed question recommended require response RICHMOND safety salicylamide scientific seal of acceptance Secretary selling Senator HRUSKA Senator KEFAUVER side effects standards statement tablets testing therapeutic therapy tion toxicity trade name WALLACE
Popular passages
Page 295 - new drug" means — (1) Any drug (except a new animal drug or an animal feed bearing or containing a new animal drug) the composition of which is such that such drug is not generally recognized, among experts qualified by scientific training and experience to evaluate the safety and effectiveness of drugs, as safe and effective for use under the conditions prescribed, recommended, or suggested in the labeling thereof, except that such a drug not so recognized shall not be deemed to be a "new drug...
Page 62 - Secretary's order. (i) The Secretary Shall promulgate regulations for exempting from the operation of the foregoing subsections of this section drugs intended solely for investigational use by experts qualified by scientific training and experience to investigate the safety and effectiveness of drugs.
Page 521 - Chairman, Subcommittee on Antitrust and Monopoly, Committee on the Judiciary, United...
Page 22 - An Act to protect trade and commerce against unlawful restraints and monopolies...
Page 886 - Labeling on or within the package from which the drug is to be dispensed bears adequate information for its use, including indications, effects, dosages, routes, methods, and frequency and duration of administration, and any relevant hazards, contraindications, side effects, and precautions...
Page 13 - To promote the progress of science and useful arts, by securing, for limited times, to authors and inventors the exclusive rights to their respective writings and discoveries; 9 To constitute tribunals inferior to the Supreme Court; 10.
Page 44 - These include the American College of Physicians, the American College of Surgeons, the American Dental Association, the American Hospital Association, and the American Medical Association.
Page 27 - The judgment of the court affirming or setting aside, in whole or in part, any action of the Secretary shall be final, subject to review by the Supreme Court of the United States upon certiorari or certification as provided in section 1254 of Title 28, United States Code.
Page 904 - ... (n) In the case of any prescription drug distributed or offered for sale in any State, unless the manufacturer, packer, or distributor thereof includes in all advertisements and other descriptive printed matter issued or caused to be issued by the manufacturer, packer, or distributor...
Page 907 - Secretary until after such application was approved, or tests by new methods, or tests by methods not deemed reasonably applicable when such application was approved, evaluated...